June 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for June 2019. This roundup includes the latest...
Soliris Approved to Treat Neuromyelitis Optica Spectrum Disorder
In clinical trials, Soliris reduced NMOSD relapses by 94 percent compared with placebo
Family History of Dementia Tied to Early Memory Deficits
Reduced paired-associates learning performance observed long before typical onset of Alzheimer disease
Infections Tied to Subsequent Risk for Acute Ischemic Stroke
Correlation highest for UTI; smaller-magnitude associations seen for UTI with intracerebral hemorrhage
Functional Decline Seen in Many Older Adults Initiating Dialysis
Prevalence of high caregiver burden increased after initiation of dialysis
Poststroke Headache Common in Pediatric Stroke Survivors
Headache more than 30 days after stroke especially likely in older pediatric stroke survivors
Migraine Prevalence Up for Food-Insecure Young Adults
Odds of migraine higher for food-insecure versus food-secure in unadjusted, adjusted analyses
Five-Year Overall Survival for Glioblastoma Persistently Low
Authors call for more aggressive treatments to be considered for glioblastoma patients
High BMI, Weight Gain Linked to Lasting Decrease in ALS Risk
Link found between high BMI, weight gain and lower risk for amyotrophic lateral sclerosis decades later
EEG May Detect Brain Activation in Some Unresponsive Patients
Clinically unresponsive brain-injured patients with EEG response to spoken commands might improve
